Genopathy
Gene-Disorder Association · Article
Gene
CHEK2
Checkpoint Kinase 2
Disorder
Breast Cancer
Manually curatedApproved treatment annotated
Association Review

In brief

The association between CHEK2 (Checkpoint Kinase 2) and Breast Cancer is well established and manually curated, with its 4 contributing sources — 2 of them expert-curated — recording pathogenic and likely-pathogenic variants and causative variation.

Sources 4
Clinical variants 3,457
Symptoms 4
Compounds 3
Trials 339of 852 via CHEK2 compounds
Publications 256
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

4 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CHEK2

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Breast Cancer

The disorder

23 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
ClinVar and variant evidence

Genetic basis

3,457 clinical variants

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
07
Population genetics

GWAS signals

1 GWAS phenotype

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
08
Genomic context

Regulatory context

2 regulatory elements

GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.

Request access
09
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
10
Interventions

Therapeutics

3 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
11
Human studies

Clinical trials

852 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
12
Literature

Reading

256 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
13
Provenance

References & sources

24 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access